Survey of vaccine distribution and delivery issues in the USA: from pediatrics to pandemics

References

• Plotkin SA, Orenstein WA. Vaccines (4th Edition). Elsevier Inc., PA, USA (2004).
   Google Scholar
• Diekema DS. Responding to parental refusals of immunization of children. Pediatrics115(5), 1428–1431 (2005).
   PubMed Web of Science ®Google Scholar
• Mackay IR, Rosen FS. Advances in immunology: vaccines and vaccination. N. Engl. J. Med.345(14), 1042–1053 (2001).
   PubMedGoogle Scholar
• Cohen ML. Changing patterns in infectious disease. Nature406, 762–767 (2000).
   PubMed Web of Science ®Google Scholar
• Cochi SL. National Immunization Survey. Presented at: The National Press Club. DC, USA 27 July 2005.
   Google Scholar
• Binder S, Levitt AM, Sacks JJ, Hughes JM. Emerging infectious diseases: public health issues for the 21st Century. Science284(5418), 1311–1313 (1999).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Recommended childhood and adolescent immunization schedule – United States. MMWR Morb. Mortal. Wkly Rep.55(51), Q1–Q4 (2007).
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Recommended adult immunization schedule – United States, October 2006 – September 2007. MMWR Morb. Mortal. Wkly Rep.55(40), Q1–Q4 (2007).
   Google Scholar
• Weniger BG. Economic analysis to meet the challenges of new combination vaccines. Presented at: Vaccine Economics: Planning a Research Agenda for the Challenge of New and Improved Vaccines. Atlanta, GA, USA, 18 December 1996.
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Vaccination coverage among children entering school — United States, 2005–2006 school year. MMWR Morb. Mortal. Wkly Rep.55(41), 1124–1126 (2006).
   PubMedGoogle Scholar
• Kroger AT, Atkinson WL, Marcuse EK, Pickering LK. General recommendations on immunization: recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb. Mortal. Wkly Rep.55(RR15), 1–48 (2006).
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). Combination vaccines for childhood immunization. MMWR Morb. Mortal. Wkly Rep.48(18), RR–5 (1999).
   Google Scholar
• Edwards KM, Decker MD. Combination vaccines. Infect. Dis. Clin. North Am.15(1), 209–230 (2001).
   PubMedGoogle Scholar
• Chen RT, DeStefano F, Pless R, Mootrey G, Kramarz P, Hibbs B. Challenges and controversies in immunization safety. Infect. Dis. Clin. North Am.15(1), 21–39 (2001).
   PubMed Web of Science ®Google Scholar
• Flanagan-Klygis EA, Sharp L, Frader JE. Dismissing the family who refuses vaccines: a study of pediatrician attitudes. Arch. Pediatr. Adolesc. Med.159(10), 929–934 (2005).
   PubMed Web of Science ®Google Scholar
• Jacobson SH, Sewell EC, Proano RA. An analysis of the pediatric vaccine shortage problem. Health Care Manag. Sci.9(4), 371–389 (2006).
   PubMedGoogle Scholar
• Sloan FA, Berman S, Rosenbaum S, Chalk RA, Giffin RB. The fragility of the U.S. vaccine supply. N. Engl. J. Med.351(23), 2443–2447 (2004).
   PubMed Web of Science ®Google Scholar
• National Vaccine Advisory Committee (NVAC). Strengthening the supply of routinely recommended vaccines in the United States. JAMA290(1), 3122–3128 (2003).
   PubMedGoogle Scholar
• Jacobson SH, Karnani T, Sewell EC. Analyzing the economic value of the hepatitis B – Haemophilus influenzae type b combination vaccine by reverse engineering a formulary selection algorithm. Vaccine21(17–18), 2169–2177 (2003).
   PubMedGoogle Scholar
• Jacobson SH, Sewell EC, Allwine DA, Medina EA, Weniger BG. Designing pediatric vaccine formularies and pricing pediatric combination vaccines using operations research models and algorithms. Expert Rev. Vaccines2(1), 15–19 (2003).
   PubMedGoogle Scholar
• Jacobson SH, Sewell EC, Karnani T. Engineering the economic value of two pediatric combination vaccines. Health Care Manag. Sci.8(1), 29–40 (2005).
   PubMedGoogle Scholar
• Parker FR. FDA Administrative Enforcement Manual. CRC Press, Taylor and Francis Group, FL, USA (2005).
   Google Scholar
• US General Accounting Office (USGAO). Report to Congressional Requestors: Childhood Vaccines. Ensuring an Adequate Supply Poses Continuing Challenges. GAO–02–987 (2002).
   Google Scholar
• Lane KS, Chu SY, Santoli JM. The United States pediatric vaccine stockpile program. Clin. Infect. Dis.42(S3), S125–S129 (2006).
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Updated recommendations on the use of pneumococcal conjugate vaccine: suspension of recommendation for third and fourth dose. MMWR Morb. Mortal. Wkly Rep.53(8), 177–178 (2004).
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). Notice to readers: pneumococcal conjugate vaccine shortage resolved. MMWR Morb. Mortal. Wkly Rep.53(36), 851–852 (2004).
   Google Scholar
• Security and Exchange Commission (SEC). Releases 33–8642, 34–52885, and IC-27178. Commission Guidance Regarding Accounting for Sales of Vaccines and Bioterror Counter-measures to the Federal Government for Placement into the Pediatric Vaccine Stockpile or the Strategic National Stockpile. USA (2005).
   Google Scholar
• Traynor K. Vaccine shortages persist despite lessons from past. Am. J. Health Syst. Pharm.61(23), 2458–2462 (2004).
   PubMedGoogle Scholar
• Klein JO, Myers MG, Strengthening the supply of routinely administered vaccines in the United States: problems and proposed solutions. Clin. Infect. Dis.42(S3), S97–S103 (2006).
   PubMed Web of Science ®Google Scholar
• Manning A. SEC ‘glitch’ hampers child vaccine. USA Today12D (2004).
   Google Scholar
• Jacobson SH, Sewell EC, Proano RA, Jokela JA. Stockpile levels for pediatric vaccines: how much is enough? Vaccine24(17), 3530–3537 (2006).
   PubMed Web of Science ®Google Scholar
• Gerdil C. The annual production cycle for influenza vaccine. Vaccine21(16), 1776–1779 (2002).
   Google Scholar
• Corbett CJ, Deo S. Cournot competition under yield uncertainty: the case of the U.S. influenza vaccine market. Technical Report. Anderson School of Management, UCLA, CA, USA (2007).
   Google Scholar
• Chick SE, Mamani H, Simchi-Levi D. “Supply chain coordination and influenza vaccination.” Technical Report. INSEAD, Fontainebleau, France (2007).
   Google Scholar
• Kalvaitis K. Pneumonia now number 1 killer in children. Infect. Dis. News20(1), 36 (2007).
   Google Scholar
• Whitney CG, Farley MM, Hadler J et al. Decline in invasive pneumococcal disease after the introduction of protein–polysaccharide conjugate vaccine. N. Engl. J. Med.348(18), 1737–1746 (2003).
   PubMed Web of Science ®Google Scholar
• Fiore AE, Shay DK, Haber P et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Morb. Mortal. Wkly Rep.56(RR06), 1–54 (2007).
   PubMedGoogle Scholar
• Hinman AR, Orenstein WA. Adult immunization: what can we learn from the childhood immunization program? Clin. Infect. Dis.44, 1532–1535 (2007).
   PubMed Web of Science ®Google Scholar
• Larson RC. Simple models of influenza progression within a heterogeneous population. Oper. Res.53(3), 399–412 (2007).
   Google Scholar
• Aaby K, Hermann JW, Jordan CS, Treadwell M, Wood K. Montgomery county’s public health service uses operations research. Interfaces36(6), 569–579 (2006).
   Web of Science ®Google Scholar
• Aaby K, Abbey RL, Hermann JW, Treadwell M, Jordan CS, Wood K. Embracing computer modeling to address pandemic influenza in the 21st Century. J. Public Health Manag. Pract.12(4), 365–372 (2006).
   PubMed Web of Science ®Google Scholar
• Miller G, Randolph S, Patterson JE. Responding to bioterrorist smallpox in San Antonio. Interfaces36(6) 580–590 (2006).
   Google Scholar
• Kaplan E, Craft D, Wein L. Emergency response to a smallpox attack: the case for mass vaccination. Proc. Natl Acad. Sci. USA99(16), 10935–10940 (2002).
   PubMed Web of Science ®Google Scholar
• Zhang XZ, Meltzer MI, Wortley PM. FluSurge – a tool to estimate demand for hospital services during the next pandemic influenza. Med. Decis. Making26(6), 617–623 (2006).
   PubMed Web of Science ®Google Scholar
• Hanfling D. Equipment, supplies, and pharmaceuticals: how much might it cost to achieve basic surge capacity? Acad. Emerg. Med.13(11), 1232–1237 (2006).
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits. Sixtieth World Health Assembly. Agenda Item 12.1, WHA60.28, Geneva, Switzerland 23 May 2007.
   Google Scholar
• Kieny MP, Costa A, Hombach J et al. A global pandemic influenza vaccine action plan. Vaccine24(40–41), 6367–6370 (2006).
   PubMedGoogle Scholar
• Health and Humans Services (HHS). Request for Information (RFI): guidance for prioritization of pre-pandemic and pandemic influenza vaccine. Fed. Regist.71(240), 75252–75253 (2006).
   Google Scholar
• Maloney L. Are we prepared? Am. J. Health Syst. Pharm.64(2), 146 (2007).
   PubMedGoogle Scholar
• Markel H, Lipman HB, Navarro JA et al. Nonpharmaceutical interventions implemented by US cities during the 1918–1919 influenza pandemic. JAMA298, 644–654 (2007).
   Google Scholar
• Hatchett RJ, Mecher CE, Lipsitch M. Public health intervention and epidemic intensity during the 1918 influenza pandemic. Proc. Natl Acad. Sci. USA104(18), 7582–7587 (2007).
   PubMed Web of Science ®Google Scholar
• Grais RF, Ellis JH, Kress A, Glass GE. Modeling the spread of annual influenza epidemics in the U.S.: the potential role of air travel. Health Care Manag. Sci.7(2), 127–134 (2004).
   PubMedGoogle Scholar
• Infectious Disease News (IDN). Global strategy aims for effective malaria vaccine by 2025. Infect. Dis. News20(1), 45 (2007).
   Google Scholar
• Pigliacelli LA. H9N2 adjuvant avian flu vaccine shows strong response. Infect. Dis. News20(1), 26 (2007).
   Google Scholar
• Trust for America’s Health. Pandemic flu and the potential for U.S. economic recession: a state-by-state analysis. Issue Report. March (2007).
   Google Scholar